• Reduces urgency and frequency of urination
• Helps reduce episodes of urge incontinence
• Improves quality of life by enhancing bladder control
• Convenient once‑daily dosing
• Full treatment effect established within weeks when used consistently

1. Take one 5 mg tablet once daily, with or without food, or as directed by your physician. 
2. Swallow the tablet whole with a glass of water; do not crush or chew.
3. If treatment is being started, your doctor may evaluate after 4 weeks to determine if dose adjustment is needed. 
4. Continue therapy even if symptoms improve — abrupt discontinuation may reduce benefit.
5. If you miss a dose, take it as soon as you remember unless it is nearly time for your next dose; do not double dose.

Q: What is this drug used for?
A: It’s used for adult patients who experience symptoms of overactive bladder, such as urgency, frequency, and urge incontinence.

Q: How long until I see results?
A: Some benefit may be seen early, but the full effect often requires about 4 weeks of regular use.

Q: Can I drive while taking it?
A: Possibly — because blurred vision or dizziness may occur, you should evaluate how you feel before driving or using machinery.

Q: Are there age restrictions?
A: Yes — use in children under 18 years is not established; elderly patients may need closer monitoring.

Q: Can men and women both use it?
A: Yes — it is indicated for adult men and women with OAB symptoms unless contraindicated.

• Do not use if you have urinary retention, severe gastrointestinal obstruction (such as gastric retention), or uncontrolled narrow‑angle glaucoma. 
• Use with caution in patients with severe renal impairment (ClCr < 30 mL/min) or moderate hepatic impairment (Child‑Pugh B) — dose should not exceed 5 mg once daily in these cases. 
• Concurrent use of potent CYP3A4 inhibitors (e.g., ketoconazole) can raise drug levels; dose should be restricted to 5 mg daily. 
• May cause dry mouth, blurred vision or constipation; monitor especially in elderly. 
• Avoid in children under 18 years: safety and efficacy not established.